New Data at AAN 2021 from Across Biogen’s MS Portfolio Demonstrate Positive Impact of Treatment on People Living with Relapsing Multiple Sclerosis

by NASDAQ Market News April 16, 2021

NASDAQ Market News
Click here to email author

Zogenix Presents New Data from a Study Highlighting the Impact of Treatment with FINTEPLA® (Fenfluramine) Oral Solution on Dravet Syndrome Patients, Caregivers, and Families at Virtual AAN 2021

Bone Morphogenetic Protein Market Research Report by Type, by Application – Global Forecast to 2025 – Cumulative Impact of COVID-19

Ads